Selected ebselen analogs reduce mechlorethamine toxicity in vitro.

Area of Science:

• Toxicology
• Medicinal Chemistry
• Biochemistry

Background:

• Sulfur mustard (SM) is a potent vesicant with no effective antidote, posing a significant threat.
• Mechlorethamine (HN2) serves as a surrogate agent to study SM toxicity.
• Developing medical countermeasures for vesicant exposure is crucial.

Purpose of the Study:

• To evaluate the protective potential of organoselenium analogs against HN2-induced toxicity in cultured A-431 skin cells.
• To assess the efficacy of ebselen (EB-1) and related compounds (EB-2, EB-3, EB-4) in mitigating HN2 damage.
• To investigate the impact of organoseleniums on HN2-induced lipid peroxidation.

Main Methods:

• Cultured A-431 skin cells were exposed to HN2 (25 µM) for 24 or 48 hours.
• Cells were co-treated with varying concentrations of organoselenium compounds (EB-1 to EB-4).
• Cell viability was assessed, and lipid peroxidation levels were measured. Light microscopy was used for confirmation.

Main Results:

• HN2 exposure caused significant cell death, while organoselenium compounds alone had minimal impact.
• All tested organoselenium analogs (EB-1 to EB-4) protected A-431 cells from HN2-induced toxicity.
• EB-4 exhibited the highest efficacy in preventing cell death and reducing HN2-induced lipid peroxidation.

Conclusions:

• Organoselenium compounds, particularly EB-4, show promise in protecting skin cells from vesicant toxicity.
• These findings support the development of organoselenium antioxidants as medical countermeasures against sulfur mustard and related agents.
• Further research into organoselenium analogs could lead to effective treatments for vesicant exposure.